KalVista Pharmaceuticals Balance Sheet (2014-2025) | KALV

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Oct2020	Jan2021	Apr2021	Jul2021	Oct2021	Jan2022	Apr2022	Jul2022	Oct2022	Jan2023	Apr2023	Jul2023	Oct2023	Jan2024	Apr2024	Jul2024	Oct2024	Dec2024	Apr2025	Jul2025
Assets
Current Assets
Cash & Equivalents (Quarter)	16.17M	17.73M	50.59M	48.34M	46.49M	45.58M	30.73M	37.86M	38.59M	85.05M	56.24M	49.41M	57.67M	23.06M	31.79M	31.85M	41.58M	182.33M	131.62M	124.30M
Short-term Investments (Quarter)	39.70M	32.58M	198.34M	182.29M	163.32M	149.21M	135.47M	104.21M	83.69M	86.64M	93.14M	73.85M	45.51M	52.53M	178.61M	142.42M	94.19M	86.02M	89.00M	67.16M
Cash & Current Investments (Quarter)	55.87M	50.31M	248.93M	230.63M	209.81M	194.79M	166.20M	142.07M	122.27M	171.69M	149.38M	123.26M	103.17M	75.59M	210.40M	174.27M	135.78M	268.35M	220.62M	191.47M
Receivables - Net (Quarter)																				1.90M
Receivables - Other (Quarter)
Receivables (Quarter)																				1.90M
Prepaid Assets (Quarter)	1.52M	4.60M	4.92M	5.54M	7.27M	8.39M	8.40M	11.08M	8.91M	2.52M	2.58M	2.84M	1.78M	2.96M	2.83M	3.07M	5.41M	6.22M	19.69M	1.46M
Current Assets (Quarter)	72.08M	62.50M	264.26M	249.78M	234.48M	214.46M	193.65M	170.41M	151.22M	192.13M	172.33M	149.84M	128.61M	104.10M	225.69M	191.63M	152.27M	285.98M	241.69M	205.90M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	1.89M	1.87M	1.79M	1.94M	2.18M	2.21M	2.18M	3.03M	3.06M	3.04M	2.95M	2.81M	2.50M	2.42M	2.23M	2.10M	2.04M	1.88M	1.99M	2.07M
Other Non-Current Assets (Quarter)	0.18M	0.18M	0.20M	0.20M	0.19M	0.19M	0.19M	0.22M	0.20M	0.20M	0.11M	0.11M	0.34M	0.40M	0.57M	0.60M	0.66M	1.38M	1.55M	2.38M
Non-Current Assets (Quarter)	3.37M	3.70M	7.75M	9.35M	9.33M	10.59M	10.23M	11.91M	11.62M	11.34M	10.88M	10.49M	10.14M	9.87M	9.71M	8.56M	8.56M	8.84M	9.08M	9.61M
Assets (Quarter)	75.45M	66.21M	272.01M	259.13M	243.81M	225.05M	203.88M	182.32M	162.84M	203.47M	183.20M	160.33M	138.74M	113.97M	235.40M	200.20M	160.83M	294.82M	250.77M	215.50M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	2.17M	0.64M	1.98M	1.45M	3.16M	2.19M	3.64M	2.91M	3.38M	1.70M	4.82M	5.06M	4.90M	3.10M	9.11M	10.79M	5.20M	5.73M	4.88M	5.87M
Notes Payables (Quarter)
Payables (Quarter)	2.17M	0.64M	1.98M	1.45M	3.16M	2.19M	3.64M	2.91M	3.38M	1.70M	4.82M	5.06M	4.90M	3.10M	9.11M	10.79M	5.20M	5.73M	4.88M	5.87M
Accumulated Expenses (Quarter)	2.95M	5.29M	6.93M	5.88M	2.40M	6.45M	6.96M	5.83M	3.09M	4.12M	4.21M	2.50M	3.85M	5.46M	6.69M	10.36M	6.98M	8.34M	27.31M	18.97M
Other Accumulated Expenses (Quarter)	0.08M	0.12M	0.39M	0.18M	0.19M	0.19M	0.31M	0.22M	0.22M	0.29M	0.20M	0.15M	0.31M	0.14M	0.25M	1.31M	0.28M	0.69M	0.81M	0.68M
Short term Debt (Quarter)
Current Leases (Quarter)	0.42M	0.59M	0.86M	0.91M	0.93M	1.01M	0.98M	1.00M	1.03M	1.06M	1.09M	1.12M	1.15M	1.19M	1.30M	1.26M	1.44M	1.45M	1.98M	2.12M
Current Deferred Revenue (Quarter)																			11.00M	11.41M
Total Current Liabilities (Quarter)	9.54M	6.52M	9.77M	8.23M	10.11M	9.65M	11.58M	9.73M	11.32M	11.61M	15.03M	14.13M	17.75M	19.13M	22.81M	22.41M	22.16M	26.11M	45.17M	38.38M
Non-Current Liabilities
Capital Leases (Quarter)
Non-Current Debt (Quarter)
Convertible Debt (Quarter)
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)	0.93M	1.12M	5.05M	6.47M	6.22M	7.47M	7.21M	8.01M	7.71M	7.42M	7.14M	6.87M	6.55M	6.26M	6.01M	4.99M	4.34M	4.44M	4.33M	4.02M
Other Non-Current Liabilities (Quarter)																		99.91M
Total Non-Current Liabilities (Quarter)	0.93M	1.12M	5.05M	6.47M	6.22M	7.47M	7.21M	8.01M	7.71M	7.42M	7.14M	6.87M	6.55M	6.26M	6.01M	4.99M	4.67M	30.55M	110.21M	136.34M
Total Liabilities (Quarter)	10.47M	7.64M	14.82M	14.70M	16.34M	17.12M	18.79M	17.75M	19.02M	19.03M	22.18M	21.00M	24.30M	25.39M	28.82M	27.40M	26.84M	130.46M	155.38M	174.72M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)	64.98M	58.56M	257.19M	244.43M	227.47M	207.94M	185.09M	164.57M	143.81M	184.44M	161.03M	139.34M	114.45M	88.58M	206.58M	172.80M	133.99M	164.36M	95.39M	40.79M
Shareholder's Equity (Quarter)	64.98M	58.56M	257.19M	244.43M	227.47M	207.94M	185.09M	164.57M	143.81M	184.44M	161.03M	139.34M	114.45M	88.58M	206.58M	172.80M	133.99M	164.36M	95.39M	40.79M
Liabilities and Shareholders Equity (Quarter)	75.45M	66.21M	272.01M	259.13M	243.81M	225.05M	203.88M	182.32M	162.84M	203.47M	183.20M	160.33M	138.74M	113.97M	235.40M	200.20M	160.83M	294.82M	250.77M	215.50M
Retained Earnings (Quarter)	-1.96M	-152.88M	-1.43M	-183.90M	-203.59M	-226.06M	-250.18M	-273.22M	-5.33M	-3.54M	-3.06M	-2.89M	-396.00M	-3.29M	-3.49M	-2.87M	-2.70M	-2.42M	-653.17M	-6.39M
Treasury Shares (Quarter)											0.74M				0.63M				0.18M

Research Tools

KalVista Pharmaceuticals Balance Sheet (2014-2025) | KALV

Create an account

Sign In

Reset Password